UPDATE: The video for this webinar is now available.

We’re pleased to announce that the Centers of Biomedical Research Excellence (COBRE) Phase 3 notice of funding opportunity (NOFO) (PAR-23-216) has been reissued. The COBRE program supports the establishment and development of innovative biomedical and behavioral research centers at Institutional Development Award (IDeA)-eligible institutions. The goal of this NOFO is to solidify the research base built in Phases 1 and 2 through continued support of research and research infrastructure and to implement strategies to sustain research excellence beyond COBRE funding.

Application due date: September 26, 2023
Earliest start date: July 2024

We’re pleased to announce that we’ve published two notices of special interest (NOSI) calling for applications to PAR-19-313, Centers of Biomedical Research Excellence (COBRE) Phase 1 (P20 Clinical Trial Optional), that focus on research on women’s health (NOT-GM-21-056) and data sciences (NOT-GM-21-062).

These NOSIs highlight the Office of Research on Women's Health's interest in supporting a meritorious application on women's health, and the Office of Data Science Strategy’s interest in supporting a meritorious application on data science relevant to biomedical research. Applications for these NOSIs must be submitted in response to and meet all eligibility criteria of PAR-19-313.